tirzepatide and glp-1 vs. Semaglutide: What You Should Know Beyond glycemia: Comparing tirzepatide to

Nature 379:6972

We often explain peptides as supporting the environment inside the body so it can function more efficiently, rather than as a quick fix

PubMed Arias F, Orio L, eds

Developed in the 1980s by Victor Hruby's team at the University of Arizona as a potential photo-protector to prevent skin cancer, MT-II is a non-selective pan-agonist of all five melanocortin receptors MC1R to MC5R, with sub-nanomolar affinity

It plays a significant role in enhancing skin health by accelerating cell turnover

The compound also supports cellular detoxification, helping to remove toxins that may contribute to skin inflammation and pigmentation issues